drugset / Trial / NCT00707330

Study of the Ability of Clarithromycin to Induce Oxidative Stress

NCT00707330

Phase 1 Completed 26 enrolled Rigshospitalet, Denmark
RandomizedCrossoverOpen-labelScreening

Summary

The purpose of the study is to examine whether Klacid® (Clarithromycin) will induce oxidative stress (stress from oxygen) in healthy subjects. This is done by measuring the content of a particular substance in the urine sample, which is released when the body is exposed to oxidative stress. In addition, there will also be taken blood samples, which is analysed for another substance that is indicative of oxidative stress.

Timeline

Start
2008-05
Primary completion
2008-07
Completion
2008-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Clarithromycin Small molecule 500 mg

Indications

No indication recorded.